Clinical Trial Update: Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas. [NA]

View source ↗

Summary

A clinical trial investigating using somatostatin receptor PET imaging to guide radiotherapy dose escalation in high-risk meningiomas; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Snippet

Sponsor: Centro di Riferimento Oncologico - Aviano | Conditions: Meningioma | NA | Status: RECRUITING